reported that [Ser (2) exendin (1-9)], a GLP-1R agonist, significantly attenuated kainic acid-induced apoptosis in the CA3 region of the hippocampus (117)
This simple step can open the door to a medically supervised plan tailored to your unique needs
1 Month Over several weeks, blood pressure and blood sugar may begin to stabilize, often leading to clearer thinking and better energy. 3 Months With consistent use, SGLT2 Inhibitors may mimic steady calorie restriction, activating longevity pathways that may clear senescent cells and reduce inflammation. 6 Months By 6 months, Invokana may encourage moderate weight loss of 2-4% body weight, potentially improving VO2 max with measurable reductions in diabetes and heart disease risk. 1 Year+ The true benefits of SGLT2 Inhibitors emerge, potentially offering increased protection against heart disease, kidney disease, dementia, and overall mortality. Given the ample preclinical and clinical evidence, SGLT2 inhibitors remain at the top of the list of potential gerotherapeutic drugs Michael Leone & Nir Barzilai, An Updated Prioritization of Geroscience Why AgelessRx
La evidencia sugiere que combinar estos macronutrientes en comidas balanceadas, siguiendo patrones como la dieta mediterrnea recomendada por la American Diabetes Association, puede apoyar la funcin metablica saludable y potencialmente optimizar la respuesta del GLP-1
Additionally, future studies will be required to assess the efficacy and safety of tirzepatide among individuals with MASH and F0 fibrosis as well as among those with MASH-cirrhosis
